M C27 (Clopidogrel bisulfate 75 mg (base))
Pill imprint M C27 has been identified as Clopidogrel bisulfate 75 mg (base).
Clopidogrel is used in the treatment of ischemic stroke; transient ischemic attack; heart attack; peripheral arterial disease; acute coronary syndrome (and more), and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Clopidogrel 75 mg (base) is not subject to the Controlled Substances Act.
See also related documents.
Images for M C27 (Clopidogrel bisulfate 75 mg (base))
- 75 mg (base)
- Prescription only
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
sodium lauryl sulfate
More about clopidogrel
- Other brands: Plavix
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...